Smoking and the Pathogenesis of Atherosclerosis

  • Henry C. McGillJr.
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 273)


This symposium occurs just a little over 30 years after the landmark study of Hammond and Horn (1958) that, for the first time, conclusively linked smoking with coronary heart disease and other sequelae of atherosclerosis. The effect of that report is difficult to appreciate with our present knowledge, but one measure of its significance is that as late as 1948, coronary heart disease patients were included as controls for studies of smoking and lung cancer (Doll, 1984). Many changes have occurred since 1958: the prevalence of smoking among U.S. adults has declined by more than a half , and the coronary heart disease death rate has declined by one third. The association of smoking with atherosclerotic cardiovascular disease has been strengthened by hundreds of observational studies which have been so unanimous in their results that the question about smoking and atherosclerotic disease is no longer whether, but how. The observation that cessation of smoking reduced risk of coronary heart disease further strengthened the idea of a causal relationship. On the question of mechanisms, we are much less informed. As the presentations in this symposium will probably show, there are many possibilities, but few certainties.


Coronary Heart Disease Atherosclerotic Disease Cholesteryl Ester Transfer Protein Coronary Heart Disease Patient High Density Lipoprotein Cholesterol Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anitschov, N.N., 1967, A history of experimentation on arterial atherosclerosis in animals. in: “Cowdry’s Arteriosclerosis: A Survey of the Problem”, 2nd ed. Charles C. Thomas, Springfield, I11. p. 21–44.Google Scholar
  2. Benditt, E.P., 1988, Origins of human atherosclerotic plaques. The role of altered gene expression. Arch. Pathol. Lab. Med. 112:997–1001.PubMedGoogle Scholar
  3. Brown, M.S., and Goldstein, J.L., 1986, A receptor-mediated pathway for cholesterol homeostasis. Science 232:34–47.PubMedCrossRefGoogle Scholar
  4. Dawber, T.R., Moore, F.E., and Mann, G.V., 1957, Coronary heart disease in the Framingham Study. Am. J. Pub. Health 47(Suppl.): 4–24.PubMedGoogle Scholar
  5. Doll, R., 1984, Smoking and death rates. JAMA 251:2854–2857.PubMedCrossRefGoogle Scholar
  6. Ernst, E., Hammerschmidt, D.E., Bagge, U., Matrai, A., and Dormandy, J.A., 1987, Leukocytes and the risk of ischemic diseases. JAMA 257:2318–2324.PubMedCrossRefGoogle Scholar
  7. Friedman, G.D., Klatsky, A.L., and Siegelaub, A.B., 1974, The leukocyte count as a predictor of myocardial infarction. N. Engl. J. Med. 290:1275–1278.PubMedCrossRefGoogle Scholar
  8. Friedman, G.D., Siegelaub, A.B., Seltzer, C.C., Feldman, R., and Collen, M.F., 1973, Smoking habits and the leukocyte count. Arch. Environ. Health 26:137–143.PubMedGoogle Scholar
  9. Garrison, R.J., Kannel, W.B., Feinleib, M., Castelli, W.P., McNamara, P.M., and Padgett, S.J., 1978, Cigarette smoking and HDL cholesterol. The Framingham Offspring Study. Atherosclerosis 30:17–25.PubMedCrossRefGoogle Scholar
  10. Goldstein, J.L., Ho, Y.K., Basu, S.K., and Brown, M.S., 1979, Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoproteins, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76:333–337.PubMedCrossRefGoogle Scholar
  11. Hammond, E.C., and Horn, D., 1958, Smoking and death rates — Report on forty-four months of follow-up of 187,783 men. JAMA 166:1294–1308.CrossRefGoogle Scholar
  12. Henriksen, T., Mahoney, E.M., and Steinberg, D., 1983, Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 3:149–159.PubMedCrossRefGoogle Scholar
  13. Holman, R.L., McGill, H.C., Jr., Strong, J.P., and Geer, J.C., 1958, The natural history of atherosclerosis. The early aortic lesions as seen in New Orleans in the middle of the 20th century. Am. J Pathol. 34:209–235.PubMedGoogle Scholar
  14. Ignatovski, A.I., 1908, [Influence of animal food on the organisms of rabbits].J Izv. Imp. Voyenno-Med. Akad., S.-Petersburg 16:154–176.Google Scholar
  15. Kaprio, J., Ferrell, R.E., Kottke, B.A., and Sing, C.F., 1989, Smoking and reverse cholesterol transport: evidence for gene-environment interaction. Clin. Genet. 36:266–268.PubMedCrossRefGoogle Scholar
  16. Knoke, J.D., Hunninghake, D.B., and Heiss, G., 1987, Physiological markers of smoking and their relation to coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial. Arteriosclerosis 7:477–482.PubMedCrossRefGoogle Scholar
  17. Kondo, I., Berg, K., Drayna, D., and Lawn, R., 1989, DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin. Genet. 35:49–56.PubMedCrossRefGoogle Scholar
  18. Lipid Research Clinics Program, 1984, The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease. JAMA 251:351–364.Google Scholar
  19. Lusis, A.J., 1988, Genetic factors affecting blood lipoproteins: the candidate gene approach. J. Lipid Res. 29:397–429.PubMedGoogle Scholar
  20. McGill, H.C., Jr., 1968, Fatty streaks in the coronary arteries and aorta. Lab Invest. 18:560–564.PubMedGoogle Scholar
  21. McGill, H.C., Jr., Geer, J.C., and Strong, J.P., 1963, Natural history of human atherosclerotic lesions, in: “Atherosclerosis and Its Origin,” M. Sandler and G.H. Bourne, ed., Academic Press, New York. p. 39–65.Google Scholar
  22. McGill, H.C., Jr., and Stern, M.R., 1979, Sex and atherosclerosis. Atheroscler. Rev. 4:157–242.Google Scholar
  23. National Research Council, Committee on Diet and Health, 1989, “Diet and Health: Implications for Reducing Chronic Disease Risk”. Chapter 7: Fats and Other Lipids. Washington, D.C. National Academy Press. p. 159–258.Google Scholar
  24. Shain, S.A., Lin, A.L., and McGill, H.C., Jr., 1988, Steroid receptors in the cardiovascular system. in: “Steroid Receptors and Disease: Cancer, Autoimmune, Bone, and Circulatory Disorders,” P.J. Sheridan, K. Blum, and M.C. Trachtenberg, eds. Marcel Dekker, Inc., New York. p. 547–567.Google Scholar
  25. Scanu, A.M., 1988, Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis. Arch. Pathol. Lab. Med. 112:1045–1047.PubMedGoogle Scholar
  26. Solberg, L.A., and Strong, J.P., 1983, Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis 3:187–198.PubMedCrossRefGoogle Scholar
  27. Stary, H.C., 1989, Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 9(Suppl):I-19-I-32.Google Scholar
  28. Strong, J.P., and Richards, M.L., 1976, Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis 23:451–476.PubMedCrossRefGoogle Scholar
  29. U.S. Office on Smoking and Health, 1983, “The Health Consequences of Smoking: Cardiovascular Disease; a Report of the Surgeon General”. Washington, D.C: U.S. Government Printing Office, 13–62.Google Scholar
  30. Utermann, G., 1989, The mysteries of lipoprotein(a) . Science 246:904–910.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Henry C. McGillJr.
    • 1
    • 2
  1. 1.Department of PathologyThe University of Texas Health Science CenterSan AntonioUSA
  2. 2.Southwest Foundation for Biomedical ResearchSan AntonioUSA

Personalised recommendations